Education
About Us
Working with TipRanks
Follow Us
Senzime AB (SE:SEZI)
:SEZI
Earnings Data
Report Date
Aug 22, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.17Last Year’s EPS
-0.28Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Date:Apr 22, 2025
|% Change Since: 22.72%
|Next Earnings Date:Aug 22, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong sales growth and successful market expansion, particularly in the U.S. and Asia. The launch of the next generation TetraGraph and successful capital raise were notable achievements. However, challenges such as currency effects, softer monitor sales in the U.S., and slower growth in Europe were acknowledged. Overall, the positive achievements outweighed the challenges.Company Guidance
In the Q3 2024 earnings call for Senzime, CEO Philip Siberg reported robust financial performance with SEK 17.4 million in sales, marking a 90% year-over-year growth, despite negative currency effects impacting the top line. The U.S. market, which constitutes 75% of their business, experienced an 81% increase in sales. The company has placed nearly 2,900 TetraGraph systems globally, with a utilization rate approaching 0.5 million monitored patients. Siberg highlighted that the company's long-term goals include reaching SEK 250-350 million in revenue by 2026 and achieving SEK 1 billion in sales eventually. The recent SEK 86 million capital raise and the introduction of the next-generation TetraGraph system aim to boost gross margins and maintain scalable operations. Despite a temporarily softer gross margin in Q3 due to U.S. pricing dynamics, the outlook remains positive with continued growth in sensor sales across the U.S. and Asia, and strategic partnerships to foster market expansion.Strong Sales Growth
Achieved SEK 17.4 million in sales for Q3 2024, corresponding to 90% sales growth, with the U.S. market growing by 81%.
Expansion and Market Penetration
Secured over 500 hospitals with the TetraGraph system and achieved significant hospital wins, including a major U.S. healthcare system.
Successful Capital Raise
Raised SEK 86 million through a directed share issue to both existing and new investors.
Launch of Next Generation TetraGraph
Introduced the next generation TetraGraph, featuring advanced features and increased accuracy, receiving positive market feedback.
Partnership Success in Asia
Strong growth in Asian markets, particularly in Japan and South Korea, driven by partnerships with local companies.
SE:SEZI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SE:SEZI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 22, 2025 | kr3.83 | kr4.58 | +19.45% |
Feb 17, 2025 | kr5.70 | kr5.92 | +3.86% |
Nov 06, 2024 | kr6.48 | kr6.35 | -2.01% |
Aug 26, 2024 | kr8.85 | kr8.00 | -9.60% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Senzime AB (SE:SEZI) report earnings?
Senzime AB (SE:SEZI) is schdueled to report earning on Aug 22, 2025, TBA Not Confirmed.
What is Senzime AB (SE:SEZI) earnings time?
Senzime AB (SE:SEZI) earnings time is at Aug 22, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Senzime AB stock?
The P/E ratio of Senzime AB is N/A.
What is SE:SEZI EPS forecast?
SE:SEZI EPS forecast for the fiscal quarter 2025 (Q2) is -0.17.